359 related articles for article (PubMed ID: 10779123)
1. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
Brown L; Ooi SY; Lau K; Sernia C
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
[TBL] [Abstract][Full Text] [Related]
2. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
Allan A; Fenning A; Levick S; Hoey A; Brown L
Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
[TBL] [Abstract][Full Text] [Related]
3. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
Nunes VW; Fortes ZB; Nigro D; Carvalho MH; Zorn TM; Scivoletto R
Gen Pharmacol; 2000 Feb; 34(2):117-25. PubMed ID: 10974419
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
Mirkovic S; Seymour AM; Fenning A; Strachan A; Margolin SB; Taylor SM; Brown L
Br J Pharmacol; 2002 Feb; 135(4):961-8. PubMed ID: 11861324
[TBL] [Abstract][Full Text] [Related]
5. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Chan V; Hoey A; Brown L
Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
[TBL] [Abstract][Full Text] [Related]
6. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
O'Brien D; Chunduri P; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
Loch D; Hoey A; Brown L
Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
[TBL] [Abstract][Full Text] [Related]
9. l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats.
Fenning A; Harrison G; Rose'meyer R; Hoey A; Brown L
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1408-16. PubMed ID: 15923320
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
[TBL] [Abstract][Full Text] [Related]
11. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
12. Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation.
Lima VV; Giachini FR; Choi H; Carneiro FS; Carneiro ZN; Fortes ZB; Carvalho MH; Webb RC; Tostes RC
Hypertension; 2009 Feb; 53(2):166-74. PubMed ID: 19139380
[TBL] [Abstract][Full Text] [Related]
13. Comparison of inotropic and chronotropic responses in rat isolated atria and ventricles.
Brown L; Sernia C; Newling R; Fletcher P
Clin Exp Pharmacol Physiol; 1991 Nov; 18(11):753-60. PubMed ID: 1664304
[TBL] [Abstract][Full Text] [Related]
14. Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate-salt rat.
Soltis EE; Field FP
Hypertension; 1986 Jun; 8(6):526-32. PubMed ID: 3710558
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
[TBL] [Abstract][Full Text] [Related]
16. Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats.
Brown L; Sernia C; Newling R; Fletcher P
J Cardiovasc Pharmacol; 1992 Aug; 20(2):316-23. PubMed ID: 1381025
[TBL] [Abstract][Full Text] [Related]
17. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat.
Larivière R; Deng LY; Day R; Sventek P; Thibault G; Schiffrin EL
J Mol Cell Cardiol; 1995 Oct; 27(10):2123-31. PubMed ID: 8576929
[TBL] [Abstract][Full Text] [Related]
18. Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity.
Giachini FR; Sullivan JC; Lima VV; Carneiro FS; Fortes ZB; Pollock DM; Carvalho MH; Webb RC; Tostes RC
Hypertension; 2010 Jan; 55(1):172-9. PubMed ID: 19901158
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats.
Northcott CA; Poy MN; Najjar SM; Watts SW
Circ Res; 2002 Aug; 91(4):360-9. PubMed ID: 12193470
[TBL] [Abstract][Full Text] [Related]
20. Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats.
Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Shirataki H; Matsuoka H
J Hypertens; 2001 Apr; 19(4):795-801. PubMed ID: 11330883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
